Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9708, pp. 31 - 40
Summary Background In patients with ventricular tachycardia (VT) and a history of myocardial infarction, intervention with an implantable cardioverter...
Internal Medicine | ARRHYTHMIAS | ARREST | MEDICINE, GENERAL & INTERNAL | CARDIOVERTER-DEFIBRILLATORS | MYOCARDIAL-INFARCTION | SUDDEN CARDIAC DEATH | PREVENTION | RHYTHM | SHOCKS | ANTIARRHYTHMIC-DRUG THERAPY | ARTERY-DISEASE | Tachycardia, Ventricular - therapy | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Catheter Ablation - methods | Tachycardia, Ventricular - surgery | Coronary Disease - complications | Defibrillators, Implantable | Adolescent | Aged, 80 and over | Adult | Female | Aged | Intervention | Drugs | Heart failure | Cardiac arrhythmia | Heart attacks | Defibrillators | Mortality | Data collection | Cardiovascular disease | Quality of life | Blood clots | Myocardial infarction | Tachycardia | Fibrillation | Motivation | Clinical trials | Coronary heart disease | Survival | Catheters
Internal Medicine | ARRHYTHMIAS | ARREST | MEDICINE, GENERAL & INTERNAL | CARDIOVERTER-DEFIBRILLATORS | MYOCARDIAL-INFARCTION | SUDDEN CARDIAC DEATH | PREVENTION | RHYTHM | SHOCKS | ANTIARRHYTHMIC-DRUG THERAPY | ARTERY-DISEASE | Tachycardia, Ventricular - therapy | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Catheter Ablation - methods | Tachycardia, Ventricular - surgery | Coronary Disease - complications | Defibrillators, Implantable | Adolescent | Aged, 80 and over | Adult | Female | Aged | Intervention | Drugs | Heart failure | Cardiac arrhythmia | Heart attacks | Defibrillators | Mortality | Data collection | Cardiovascular disease | Quality of life | Blood clots | Myocardial infarction | Tachycardia | Fibrillation | Motivation | Clinical trials | Coronary heart disease | Survival | Catheters
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 03/2006, Volume 354, Issue 10, pp. 1039 - 1051
The case study of a 28-year-old woman diagnosed with supraventricular tachycardia is illustrated. Catheter ablation is appropriate for supraventricular...
ARRHYTHMIAS | MEDICINE, GENERAL & INTERNAL | FLECAINIDE ACETATE | MANAGEMENT | MEDICAL THERAPY | EFFICACY | WOLFF-PARKINSON-WHITE | ADENOSINE | RADIOFREQUENCY CATHETER ABLATION | QUALITY-OF-LIFE | NATURAL-HISTORY | Case studies | Usage | Supraventricular tachycardia | Diagnosis | Anti-arrhythmia drugs | Cardiac arrhythmia | Disease management | Medical treatment | Risk factors
ARRHYTHMIAS | MEDICINE, GENERAL & INTERNAL | FLECAINIDE ACETATE | MANAGEMENT | MEDICAL THERAPY | EFFICACY | WOLFF-PARKINSON-WHITE | ADENOSINE | RADIOFREQUENCY CATHETER ABLATION | QUALITY-OF-LIFE | NATURAL-HISTORY | Case studies | Usage | Supraventricular tachycardia | Diagnosis | Anti-arrhythmia drugs | Cardiac arrhythmia | Disease management | Medical treatment | Risk factors
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2010, Volume 106, Issue 10, pp. 1473 - 1480
Atrioventricular (AV) conduction impairment is well described after surgical aortic valve replacement, but little is known in patients undergoing transcatheter...
Cardiovascular | REPLACEMENT | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | ABNORMALITIES | BLOCK | OLDER | TERM-FOLLOW-UP | PERMANENT PACEMAKER IMPLANTATION | REQUIREMENT | Prognosis | Prospective Studies | Humans | Heart Valve Prosthesis Implantation - methods | Male | Prosthesis Design | Incidence | Cardiac Catheterization | Atrioventricular Block - etiology | Heart Valve Prosthesis Implantation - adverse effects | Aged, 80 and over | Atrioventricular Block - epidemiology | Female | Aortic Valve | Arrhythmia | Heart valve diseases
Cardiovascular | REPLACEMENT | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | ABNORMALITIES | BLOCK | OLDER | TERM-FOLLOW-UP | PERMANENT PACEMAKER IMPLANTATION | REQUIREMENT | Prognosis | Prospective Studies | Humans | Heart Valve Prosthesis Implantation - methods | Male | Prosthesis Design | Incidence | Cardiac Catheterization | Atrioventricular Block - etiology | Heart Valve Prosthesis Implantation - adverse effects | Aged, 80 and over | Atrioventricular Block - epidemiology | Female | Aortic Valve | Arrhythmia | Heart valve diseases
Journal Article
Heart Rhythm, ISSN 1547-5271, 2009, Volume 6, Issue 6, pp. 886 - 933
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTABLE-CARDIOVERTER-DEFIBRILLATORS | STRUCTURAL HEART-DISEASE | PHRENIC-NERVE INJURY | EPICARDIAL RADIOFREQUENCY ABLATION | REMOTE MAGNETIC NAVIGATION | LONG-TERM SUCCESS | MYOCARDIAL-INFARCTION PERIOD | OUTFLOW TRACT TACHYCARDIA | BUNDLE-BRANCH REENTRY | CORONARY-ARTERY-DISEASE | Arrhythmia | Medical equipment | Physiological apparatus
Journal Article
Hypertension, ISSN 0194-911X, 09/2009, Volume 54, Issue 3, pp. 530 - 536
In patients with drug-resistant hypertension, chronic electric stimulation of the carotid baroreflex is an investigational therapy for blood pressure...
Arterial hypertension | Cardiac autonomic system | Baroreflex | Drug-resistant arterial hypertension | Heart rate turbulence | Heart rate variability | Electric baroreflex stimulation | SURGICAL TECHNIQUE | baroreflex | ANGIOTENSIN HYPERTENSION | PROLONGED ACTIVATION | cardiac autonomic system | BLOOD-PRESSURE | arterial hypertension | heart rate variability | HEART-RATE TURBULENCE | PHYSIOLOGICAL INTERPRETATION | ELECTRICAL-STIMULATION | electric baroreflex stimulation | ACUTE MYOCARDIAL-INFARCTION | SYMPATHETIC-NERVE ACTIVITY | heart rate turbulence | PERIPHERAL VASCULAR DISEASE | CAROTID SINUS NERVE | drug-resistant arterial hypertension | Prospective Studies | Electric Stimulation Therapy - instrumentation | Humans | Middle Aged | Pressoreceptors - physiology | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Autonomic Nervous System - physiopathology | Hypertension - physiopathology | Cardiovascular System - physiopathology | Electric Stimulation Therapy - methods | Electrocardiography | Heart Rate - physiology | Adult | Female | Baroreflex - physiology | Blood Pressure - drug effects | Blood Pressure - physiology | Hypertension - therapy | Drug Resistance
Arterial hypertension | Cardiac autonomic system | Baroreflex | Drug-resistant arterial hypertension | Heart rate turbulence | Heart rate variability | Electric baroreflex stimulation | SURGICAL TECHNIQUE | baroreflex | ANGIOTENSIN HYPERTENSION | PROLONGED ACTIVATION | cardiac autonomic system | BLOOD-PRESSURE | arterial hypertension | heart rate variability | HEART-RATE TURBULENCE | PHYSIOLOGICAL INTERPRETATION | ELECTRICAL-STIMULATION | electric baroreflex stimulation | ACUTE MYOCARDIAL-INFARCTION | SYMPATHETIC-NERVE ACTIVITY | heart rate turbulence | PERIPHERAL VASCULAR DISEASE | CAROTID SINUS NERVE | drug-resistant arterial hypertension | Prospective Studies | Electric Stimulation Therapy - instrumentation | Humans | Middle Aged | Pressoreceptors - physiology | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Autonomic Nervous System - physiopathology | Hypertension - physiopathology | Cardiovascular System - physiopathology | Electric Stimulation Therapy - methods | Electrocardiography | Heart Rate - physiology | Adult | Female | Baroreflex - physiology | Blood Pressure - drug effects | Blood Pressure - physiology | Hypertension - therapy | Drug Resistance
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of...
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Stroke, ISSN 0039-2499, 08/2007, Volume 38, Issue 8, pp. 2292 - 2294
Background and Purpose - For patients having suffered ischemic stroke, the current diagnostic strategies often fail to detect atrial fibrillation as a...
Embolic stroke | Stroke prevention | Atrial fibrillation | atrial fibrillation | embolic stroke | INITIATION | PREVENTION | PERIPHERAL VASCULAR DISEASE | LESSONS | stroke prevention | CLINICAL NEUROLOGY | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Arrhythmia, Sinus - complications | Atrial Fibrillation - physiopathology | Stroke - physiopathology | Intracranial Embolism and Thrombosis - physiopathology | Time Factors | Intracranial Embolism and Thrombosis - etiology | Adult | Female | Atrial Fibrillation - diagnosis | Electrocardiography - methods | Stroke - prevention & control | Atrial Fibrillation - complications | Arrhythmia, Sinus - diagnosis | Brain Ischemia - physiopathology | Brain Ischemia - prevention & control | Arrhythmia, Sinus - physiopathology | Brain Ischemia - etiology | Intracranial Embolism and Thrombosis - prevention & control | Stroke - etiology | Heart Conduction System - physiopathology | Monitoring, Physiologic - methods | Aged
Embolic stroke | Stroke prevention | Atrial fibrillation | atrial fibrillation | embolic stroke | INITIATION | PREVENTION | PERIPHERAL VASCULAR DISEASE | LESSONS | stroke prevention | CLINICAL NEUROLOGY | Predictive Value of Tests | Prospective Studies | Humans | Middle Aged | Male | Arrhythmia, Sinus - complications | Atrial Fibrillation - physiopathology | Stroke - physiopathology | Intracranial Embolism and Thrombosis - physiopathology | Time Factors | Intracranial Embolism and Thrombosis - etiology | Adult | Female | Atrial Fibrillation - diagnosis | Electrocardiography - methods | Stroke - prevention & control | Atrial Fibrillation - complications | Arrhythmia, Sinus - diagnosis | Brain Ischemia - physiopathology | Brain Ischemia - prevention & control | Arrhythmia, Sinus - physiopathology | Brain Ischemia - etiology | Intracranial Embolism and Thrombosis - prevention & control | Stroke - etiology | Heart Conduction System - physiopathology | Monitoring, Physiologic - methods | Aged
Journal Article
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, ISSN 1424-3784, 05/2015, Volume 15, Issue 22
Journal Article
Heart Rhythm, ISSN 1547-5271, 06/2009, Volume 6, Issue 6, pp. 886 - 933
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 10, pp. 1728 - 1734
The value of electrocardiographic findings predicting adverse outcome in patients with arrhythmogenic right ventricular dysplasia (ARVD) is not well known. We...
Cardiovascular | ARRHYTHMIAS COMMITTEE | HEART-ASSOCIATION ELECTROCARDIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | RHYTHM SOCIETY | CLINICAL CARDIOLOGY | AHA/ACCF/HRS RECOMMENDATIONS | QRS FRAGMENTATION | OF-CARDIOLOGY FOUNDATION | INTRAVENTRICULAR-CONDUCTION DISTURBANCES | PROGNOSTIC VALUE | SCIENTIFIC STATEMENT | Risk Assessment - methods | Confidence Intervals | Reproducibility of Results | Prognosis | Survival Rate - trends | Follow-Up Studies | Death, Sudden, Cardiac - epidemiology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Arrhythmogenic Right Ventricular Dysplasia - epidemiology | Death, Sudden, Cardiac - etiology | Arrhythmogenic Right Ventricular Dysplasia - physiopathology | Incidence | Arrhythmogenic Right Ventricular Dysplasia - complications | Electrocardiography | Adult | Female | Retrospective Studies | Heart | Fainting | Dysplasia | Task forces | Tachycardia | Cardiac patients | Electrocardiogram | Medicine, Preventive | Preventive health services | Heart rate | Heart failure | Variables | Cardiac arrhythmia | Heart attacks | Values
Cardiovascular | ARRHYTHMIAS COMMITTEE | HEART-ASSOCIATION ELECTROCARDIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | RHYTHM SOCIETY | CLINICAL CARDIOLOGY | AHA/ACCF/HRS RECOMMENDATIONS | QRS FRAGMENTATION | OF-CARDIOLOGY FOUNDATION | INTRAVENTRICULAR-CONDUCTION DISTURBANCES | PROGNOSTIC VALUE | SCIENTIFIC STATEMENT | Risk Assessment - methods | Confidence Intervals | Reproducibility of Results | Prognosis | Survival Rate - trends | Follow-Up Studies | Death, Sudden, Cardiac - epidemiology | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Arrhythmogenic Right Ventricular Dysplasia - epidemiology | Death, Sudden, Cardiac - etiology | Arrhythmogenic Right Ventricular Dysplasia - physiopathology | Incidence | Arrhythmogenic Right Ventricular Dysplasia - complications | Electrocardiography | Adult | Female | Retrospective Studies | Heart | Fainting | Dysplasia | Task forces | Tachycardia | Cardiac patients | Electrocardiogram | Medicine, Preventive | Preventive health services | Heart rate | Heart failure | Variables | Cardiac arrhythmia | Heart attacks | Values
Journal Article